COVID-19 vaccination for pregnant and breastfeeding women

Description:
Although the absolute risk for severe COVID-19 in pregnancy remains low, it is now established that pregnant women are at increased risk of severe COVID-19-associated illness compared with non-pregnant women. Such illness may require hospitalisation, admission to intensive care, mechanical ventilation and even cause death. Thus, the prevention of critical COVID-19 infection is of paramount importance for both the mother and her fetus.
Based on the available evidence, FIGO considers there to be minimal risks – actual or theoretical – that would outweigh the potential benefits of vaccination for pregnant women. We therefore support offering COVID-19 vaccines to pregnant and breastfeeding women. In this webinar, leading speakers will set out FIGO’s position on COVID-19 vaccination and also explore the need for counselling skills for OBGYNs to ensure women can make informed choices. Taking a risk-based approach to the benefits of universal protection, our expert speakers will discuss the safety, efficacy and indications of the various vaccines for pregnant and breastfeeding women.
With co-chairs:
Dr Faysal El Kak (Lebanon) – Vice President, FIGO
Dr Jeanne Conry (USA) – President Elect, FIGO
Professor Dame Lesley Regan (UK) – Honorary Secretary, FIGO
Featuring:
Dr Carlos Füchtner (Bolivia) – President, FIGO
Dr Denise Jamieson (USA) – COVID-19 vaccine for pregnant and breastfeeding women: Evidence for practice
Dr Frank A. Chervenak (USA) – Recommending COVID-19 Vaccination For Pregnant and Breastfeeding Women is Ethically Obligatory
Dr Anwar Nassar (Lebanon, FIGO Safe Motherhood Committee) – FIGO stand on COVID-19 vaccines
The three short presentations will be followed by a panel discussion and audience Q&A.
Language: English